Diffusion Pharmaceuticals Inc.
AI factory platforms for accelerated computing at scale
- Sector
- Software
- Headquarters
- CHARLOTTESVILLE, VA
- Founded
- 2015
- Latest Form D
- $750K, May 2020
- Total capital
- $140M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $140M
- 9 Form D · last May 2020
- 77 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 9th filing$750K
- Private capital raisedForm D · SEC · 8th filing$625K
- Private capital raisedForm D · SEC · 7th filing$783K
- Private capital raisedForm D · SEC · 6th filing$164K
- Private capital raisedForm D · SEC · 5th filing$15.8M
- Private capital raisedForm D · SEC · 4th filing$85.7M
- Private capital raisedForm D · SEC · 3rd filing$24.8M
- Private capital raisedForm D · SEC · 2nd filing$2.6M
- Private capital raisedForm D · SEC · 1st filing$8.7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Alan G. LevinDirectorNamed in SEC Form D filings
- Ben L. ShealyExecutive OfficerNamed in SEC Form D filings
- David R. JonesExecutive OfficerNamed in SEC Form D filings
- David G. KalergisExecutive Officer, DirectorNamed in SEC Form D filings
- Isaac L. BlechDirectorNamed in SEC Form D filings
- John L. GainerExecutive Officer, DirectorNamed in SEC Form D filings
Show all 13 people
- Kim L. WhittenExecutive OfficerNamed in SEC Form D filings
- Mark T. GIlesDirectorNamed in SEC Form D filings
- Matthew W. HantzmonExecutive OfficerNamed in SEC Form D filings
- Robert W. AdamsDirectorNamed in SEC Form D filings
- Robert J. CobuzziDirectorNamed in SEC Form D filings
- Thomas E. ByrneDirectorNamed in SEC Form D filings
- William K. HornungExecutive OfficerNamed in SEC Form D filings
What it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- Rev Gum, LLCSimilar federal contract value in Software · null in contracts
- SKAI INNOVATIONS INC.Similar federal contract value in Software · null in contracts
- ActivePrime IncSimilar federal contract value in Software · null in contracts
- AssetWatch, Inc.Similar federal contract value in Software · null in contracts
- Snowflake Inc.Similar federal contract value in Software · null in contracts
- Black Swan Real Estate Secure Freedom Fund LLCSimilar federal contract value in Software · null in contracts
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .